Abstract
We examined if the adenosine A 1 receptor agonist adenosine amine congener (ADAC, 100 μg/kg i.p.) is neuroprotective in 7-day-old rats subjected to hypoxic ischemia. Brain damage, evaluated as weight deficit and gross morphology, was not affected by ADAC treatment. Nonetheless, ADAC (100 μg/kg i.p.) reduced heart rate by 44% ( p<0.0001), indicating that the dose given was pharmacologically active. Adenosine A 1 receptors were determined by [ 3H] 1,3-dipropyl-8-cyclopentylxanthine (DPCPX)-binding and levels were 23% of the adult levels. GTP did not affect [ 3H] DPCPX-binding in the cerebral cortex at postnatal day 7 whereas there was strong enhancement of [ 3H] DPCPX-binding in the heart. This suggested a poor G-protein coupling at postnatal day 7 in the brain, which also was confirmed using GTP [γ- 35S]-binding in the presence of an adenosine A 1 receptor agonist. Thus, the lack of a neuroprotective effect of ADAC may be explained by the fact that adenosine A 1 receptors are not part of a functional unit in the 7-day-old rat brain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.